Anatara Lifesciences Ltd (ASX:ANR)
Australia · Delayed Price · Currency is AUD 0.0080
0.00 (0.00%)
Nov 10, 2026, 11:13 AM AEDT
Anatara Lifesciences Market Cap
Anatara Lifesciences has a market cap or net worth of 2.53 million as of November 9, 2026. It is the 48,309th most valuable company in the world and the 1,639th biggest in Australia. Its market cap has decreased by 21.36% in one year.
Market Cap
2.53M
Enterprise Value
2.06M
Revenue
318.40K
Global Rank
Country Rank
#1,639 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since October 16, 2014, Anatara Lifesciences's market cap has decreased from 9.98M to 2.53M, a decrease of -74.66%. That is a compound annual growth rate of -10.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 2.53M | -42.43% |
| Dec 31, 2025 | 4.39M | -56.22% |
| Dec 27, 2024 | 10.03M | 171.52% |
| Dec 22, 2023 | 3.69M | -2.18% |
| Dec 30, 2022 | 3.78M | -62.20% |
| Dec 31, 2021 | 9.99M | -16.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cambium Bio | 10.60M |
| AdAlta | 9.64M |
| Tissue Repair | 7.86M |
| Invex Therapeutics | 6.76M |
| Zelira Therapeutics | 5.95M |
| Bio-Gene Technology | 5.69M |
| Biotron | 5.57M |
| Acrux | 5.31M |